InvestSMART

BlinkLab Limited (ASX: BB1) - Announcements

Current share price for BB1 : $0.625 0.005 (0.79%)+

ASX company news and announcements for BlinkLab Limited (BB1) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All BlinkLab Limited (BB1) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than BlinkLab Limited (BB1), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for BlinkLab Limited (BB1)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$110 Pause in Trading 31 Mar 2025 10:01AM $0.385 $0.625 risen by 62.34%
$110 Brokers meet Biotech Presentation 20 Mar 2025 1:51PM $0.440 $0.625 risen by 42.05%
$110 Blinklab Expands Autism Diagnostics into Adults 19 Mar 2025 9:01AM $0.395 $0.625 risen by 58.23%
$110 US Autism Diagnostic Study Commences with First Child Tested 12 Mar 2025 8:58AM $0.355 $0.625 risen by 76.06%
$110 Section 708(A) Notice 27 Feb 2025 7:05PM $0.445 $0.625 risen by 40.45%
$110 Application for quotation of securities - BB1 27 Feb 2025 6:58PM $0.445 $0.625 risen by 40.45%
$110 Half Yearly Report and Accounts 26 Feb 2025 7:41PM $0.345 $0.625 risen by 81.16%
$110 North Shore Pediatric Therapy in Chicago joins Study 10 Feb 2025 9:11AM $0.425 $0.625 risen by 47.06%
$110 BlinkLab Initiates its First US-based Clinical Site 5 Feb 2025 9:32AM $0.405 $0.625 risen by 54.32%
$110 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jan 2025 3:03PM $0.280 $0.625 risen by 123.21%
$110 Change of Director's Interest Notice 14 Jan 2025 10:25AM $0.263 $0.625 risen by 138.10%
$110 Change of Director's Interest Notice 14 Jan 2025 10:20AM $0.263 $0.625 risen by 138.10%
$110 Change of Director's Interest Notice 10 Jan 2025 10:10AM $0.270 $0.625 risen by 131.48%
$110 Change of Director's Interest Notice 10 Jan 2025 9:35AM $0.270 $0.625 risen by 131.48%
$110 Change of Director's Interest Notice 10 Jan 2025 9:21AM $0.270 $0.625 risen by 131.48%
$110 Change of Director's Interest Notice 7 Jan 2025 8:16AM $0.270 $0.625 risen by 131.48%
$110 Change of Director's Interest Notice 31 Dec 2024 10:35AM $0.285 $0.625 risen by 119.30%
$110 Positive Outcome from FDA Pre-Submission Meeting 19 Dec 2024 9:42AM $0.245 $0.625 risen by 155.10%
$110 Trading Halt 18 Dec 2024 11:05AM $0.245 $0.625 risen by 155.10%
$110 Pause in Trading 18 Dec 2024 11:00AM $0.245 $0.625 risen by 155.10%
$110 Application for quotation of securities - BB1 16 Dec 2024 8:22AM $0.250 $0.625 risen by 150%
$110 Notice of Release of Escrowed Securities 9 Dec 2024 1:49PM $0.275 $0.625 risen by 127.27%
$110 Amended BB1 to Participate in Monash Uni Autism/ADHD MAGNET 21 Nov 2024 10:28AM $0.285 $0.625 risen by 119.30%
$110 Corporate Presentation 20 Nov 2024 9:57AM $0.310 $0.625 risen by 101.61%
$110 Large-Scale Study Validates Accuracy in Detecting Autism 19 Nov 2024 9:53AM $0.260 $0.625 risen by 140.38%

126 - 150 of 199 results

Page 6 of 8

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.